Impact of immunization with Protein F on pulmonary clearance of nontypeable Haemophilus influenzae.

Research output: Contribution to journalArticlepeer-review

10 Citations (SciVal)

Abstract

Nontypeable Haemophilus influenzae (NTHi) is one of the main aetiologies of childhood bacterial infections as well as exacerbations in COPD patients. Currently, no licensed NTHi vaccine exists. In the present study, we evaluated the potential of the conserved and ubiquitous surface protein Haemophilus Protein F (PF) as a vaccine candidate. Our results show that incubation of NTHi with anti-PF antibodies significantly increased the opsonophygocytosis of human promyelocytic leukemia cell line-derived granulocytes, leading to efficient killing of the bacteria (P≤0.05). The presence of anti-PF IgG titers in healthy adults (n=60) was investigated, and we found that 26% of healthy blood donors carried antibodies with the main antigenic epitope being PF(23-48). Finally, mice immunized with PF(23-48) attained a significantly increased capacity to clear NTHi as compared to a control group immunized with a peptide derived from Moraxella catarrhalis β-lactamase (P≤0.05). Taken together, our results indicate that PF is a potential NTHi-vaccine candidate.
Original languageEnglish
Pages (from-to)2261-2264
JournalVaccine
Volume32
Issue number20
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Microbiology in the medical area

Fingerprint

Dive into the research topics of 'Impact of immunization with Protein F on pulmonary clearance of nontypeable Haemophilus influenzae.'. Together they form a unique fingerprint.

Cite this